Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
MC2 Therapeutics
MC2 Therapeutics
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Wynzora
Betamethasone
,
Calcipotriene
2020-07-20
2027-2039
Psoriasis
,
Atopic dermatitis
,
Pruritus ani
,
Inflammation
,
Facial dermatoses
,
Seborrheic dermatitis
,
Foot dermatoses
,
Hand dermatoses
,
Scalp dermatoses
,
Leg dermatoses
,
Mycoses
,
Oral candidiasis
,
Vulvovaginal candidiasis
,
Tinea pedis
,
Cutaneous candidiasis
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Betamethasone
healthy volunteers/patients
Calcipotriene
alopecia areata
,
vitiligo
,
localized scleroderma
,
squamous cell neoplasms
,
vasoconstriction
,
photoallergic dermatitis
,
phototoxic dermatitis
,
healthy volunteers/patients
,
systemic scleroderma
,
alopecia
,
breast neoplasms
,
connective tissue diseases
,
skin neoplasms
,
immunotherapy
,
organ transplantation
,
drug-related side effects and adverse reactions
,
mesenchymal stem cell transplantation
,
dermatitis
,
eczema
,
arthritis
,
pruritus
,
radiodermatitis
,
atopic dermatitis
,
squamous cell carcinoma
,
carcinoma
,
follicular lymphoma
,
cough
,
pharyngitis
,
dysphonia
,
hoarseness
,
basal cell carcinoma
,
carcinoma in situ
,
psoriasis
,
actinic keratosis
,
keratosis
,
skin and connective tissue diseases
,
acne vulgaris
,
coronary artery disease
,
erythema multiforme
,
skin diseases
,
papulosquamous skin diseases
,
contact dermatitis
,
graft vs host disease
,
exanthema
,
bites and stings
,
topical administration
,
allergic contact dermatitis
,
insulin resistance
,
blood coagulation disorders
,
inflammation
,
blood platelet disorders
,
hemostatic disorders
,
coagulation protein disorders
,
oral lichen planus
,
lichen planus
,
warts
Betamethasone dipropionate
healthy volunteers/patients
,
eczema
,
atrophy
,
skin and connective tissue diseases
,
connective tissue diseases
,
psoriasis
,
atopic dermatitis
,
dermatitis
,
insulin resistance
Bos taurus adrenal cortex corticosteroids
asthma
,
multiple sclerosis
,
relapsing-remitting multiple sclerosis
,
smoking
,
chronic obstructive pulmonary disease
,
lung diseases
,
obstructive lung diseases
Daivonex
alopecia areata
,
vitiligo
,
localized scleroderma
,
squamous cell neoplasms
,
vasoconstriction
,
photoallergic dermatitis
,
phototoxic dermatitis
,
healthy volunteers/patients
,
systemic scleroderma
,
alopecia
,
breast neoplasms
,
connective tissue diseases
,
skin neoplasms
,
immunotherapy
,
organ transplantation
,
drug-related side effects and adverse reactions
,
mesenchymal stem cell transplantation
,
dermatitis
,
eczema
,
arthritis
,
pruritus
,
radiodermatitis
,
atopic dermatitis
,
squamous cell carcinoma
,
carcinoma
,
follicular lymphoma
,
cough
,
pharyngitis
,
dysphonia
,
hoarseness
,
basal cell carcinoma
,
carcinoma in situ
,
psoriasis
,
actinic keratosis
,
keratosis
,
skin and connective tissue diseases
,
acne vulgaris
,
coronary artery disease
,
erythema multiforme
,
skin diseases
,
papulosquamous skin diseases
,
contact dermatitis
,
graft vs host disease
,
exanthema
,
bites and stings
,
topical administration
,
allergic contact dermatitis
,
insulin resistance
,
blood coagulation disorders
,
inflammation
,
blood platelet disorders
,
hemostatic disorders
,
coagulation protein disorders
,
oral lichen planus
,
lichen planus
,
warts
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use